Over 4,200 people set to benefit after we reccomend daily pill to treat rare chronic kidney disease
New treatment sparsentan has been found to slow down the progression of kidney damage, which will change people’s lives for the better.
News, blogs and podcasts
Latest articles
New weekly treatment option approved for people with haemophilia B
Our final draft guidance published today recommends marstacimab (also called Hympavzi and made by Pfizer) for treating the severe form of blood disorder haemophilia B in people 12 years and over.
Deal agreed for continued access to life-changing treatment for rare inherited disease
We are consulting on draft guidance for cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (CLN2), a type of Batten disease.
Technology recommended for people with chronic tic disorders and Tourette syndrome
Final guidance recommends one digital therapy to help children and young people manage their condition.
Latest in-depth
Strengthening Egypt's healthcare system through technology assessment
NICE International has helped Egypt take a crucial step towards a fairer, more efficient healthcare system.
NICE in 2024: Highlights from our 25th year
An end of year summary from our chief executive, Dr Sam Roberts.
Latest blogs
Health inequalities - an update to NICE’s methods for health technology evaluation
Our new modular update focuses on how we consider health inequalities when evaluating technologies for use in the NHS, and how you can get involved in suggesting future updates.
HST routing criteria: encouraging innovation in the treatment of ultra-rare diseases
Our chief medical officer, Professor Jonathan Benger, explains the crucial role the HST programme plays in encouraging innovation in the treatment of ultra-rare diseases. He also highlights why effective routing is essential to getting the best care to patients across the NHS.
Latest podcasts
Endometriosis - learn more about NICE's guideline for this chronic condition
Navigating the future - AI at NICE
